The Cell & Gene Unscripted Video Series

Progress in cell and gene therapy rarely comes from taking the path of least resistance. It comes from hard calls, shifting science, and leaders unafraid to question the status quo. This series digs into those decisions — and everything riding on them.

Chris Learn, Ph.D., M.B.A., P.M.P., Parexel's Head of Cell & Gene Therapy and Early Phase, hosts exclusive interviews with leading voices from across the industry to dig into the tensions and trade-offs defining where the field is headed. These discussions span topics including regulatory approach, trial execution, patient access, and real-world evidence.